Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
Annals of Surgery
|
September 26, 2018
Clinical Outcome After Rectal Replacement With Side-to-End, Colon-J-Pouch, or Straight Colorectal Anastomosis Following Total Mesorectal Excision: A Swiss Prospective, Randomized, Multicenter Trial (SAKK 40/04)
Walter R Marti, Gaudenz Curti, Heinz Wehrli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2024
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17
Michael Mark, Patrizia Froesch, Katrin Gysel, et al.
BMC Cancer
|
February 20, 2021
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)
Karin Ribi, Beat Thürlimann, Corinne Schär, et al.
Annals of Surgical Oncology
|
June 23, 2019
Quality of Life After Total Mesorectal Excision and Rectal Replacement: Comparing Side-to-End, Colon J-Pouch and Straight Colorectal Reconstruction in a Randomized, Phase III Trial (SAKK 40/04)
Karin Ribi, Walter R Marti, Jürg Bernhard, et al.
Blood
|
September 22, 2018
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma
Christoph Driessen, Rouven Müller, Urban Novak, et al.
Journal of Bone Oncology
|
January 24, 2020
Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)
Michael Mark, Beat Thürlimann, Karin Ribi, et al.
Trials
|
December 6, 2018
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial
Guido Henke, Michael Knauer, Karin Ribi, et al.
Journal of Geriatric Oncology
|
December 19, 2018
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Dirk L Kienle, Daniel Dietrich, Karin Ribi, et al.
Breast (Edinburgh, Scotland)
|
May 3, 2026
24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial
Uwe Güth, Nicolette Hoefnagels, Andreas Müller, et al.
Cancer Nursing
|
September 10, 2021
Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment: A Cluster-Randomized Study (Symptom Navi Pilot Study)
Marika Bana, Karin Ribi, Solange Peters, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
Annals of Surgery
|
September 26, 2018
Clinical Outcome After Rectal Replacement With Side-to-End, Colon-J-Pouch, or Straight Colorectal Anastomosis Following Total Mesorectal Excision: A Swiss Prospective, Randomized, Multicenter Trial (SAKK 40/04)
Walter R Marti, Gaudenz Curti, Heinz Wehrli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2024
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17
Michael Mark, Patrizia Froesch, Katrin Gysel, et al.
BMC Cancer
|
February 20, 2021
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)
Karin Ribi, Beat Thürlimann, Corinne Schär, et al.
Annals of Surgical Oncology
|
June 23, 2019
Quality of Life After Total Mesorectal Excision and Rectal Replacement: Comparing Side-to-End, Colon J-Pouch and Straight Colorectal Reconstruction in a Randomized, Phase III Trial (SAKK 40/04)
Karin Ribi, Walter R Marti, Jürg Bernhard, et al.
Blood
|
September 22, 2018
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma
Christoph Driessen, Rouven Müller, Urban Novak, et al.
Journal of Bone Oncology
|
January 24, 2020
Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)
Michael Mark, Beat Thürlimann, Karin Ribi, et al.
Trials
|
December 6, 2018
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial
Guido Henke, Michael Knauer, Karin Ribi, et al.
Journal of Geriatric Oncology
|
December 19, 2018
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Dirk L Kienle, Daniel Dietrich, Karin Ribi, et al.
Breast (Edinburgh, Scotland)
|
May 3, 2026
24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial
Uwe Güth, Nicolette Hoefnagels, Andreas Müller, et al.
Cancer Nursing
|
September 10, 2021
Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment: A Cluster-Randomized Study (Symptom Navi Pilot Study)
Marika Bana, Karin Ribi, Solange Peters, et al.
Page
of 9